Here's a link to the
primary article.
Having worked in this field, I am always amused by how someone's hard work in the basic sciences gets translated to the popular media.
Basically, these folks have shown that D1 and D2 receptors form complexes in the brain. That's new, and that's cool. They've also characterized the phamacology of this complex, using SKF83959, a well characterized research-grade dopamine agonist, hardly "discovering a new chemical" as the
Star article implies, and show that there are changes in the intracellular 2nd messenger cascades. That's important. Yes, we know that D2 antagonists are effective anti-psychotics (though they do nothing for negative symptoms). However, there's never been a lot of strong evidence of a primary disruption in dopamine receptors in schizophrenia, and this article offers essentially no claim that we would see a change in D1-D2 complexing in schizophrenics. Nevertheless, the
Star jumps right ahead to the whole "hope for a new drug" thing that you see just about every damn time a study like this gets reported. It's like the stock footage of someone in a white coat pipetting that the TV news shows everytime there's a "health care breakthrough story".
🙄
My opinion? The real breakthrough will be figuring out exactly what is the disruption in these folks' wiring, and figuring out how to prevent it before it happens. (So make sure your pregnant patients get their flu shots!)
BTW--I'll take a pleasantly psychotic patient ANY DAY rather than have to sit through another half hour of a droning, complaining chronically depressed middle-class neurotic, thank you very much!